Lynchburg Journal of Medical Science
Lung cancer is the leading cause of cancer-related death in the world; however, when caught at an early stage, stage 1 non-small cell lung cancer (NSCLC) has a more favorable prognosis than more advanced stages. There are several treatment options available for stage 1 lung cancer, but the purpose of this article is to focus on the most common treatments, which are surgery and stereotactic body radiation therapy (SBRT). Surgery is the preferred treatment modality for stage 1 lung cancer, while SBRT can be considered for inoperable patients or those who refuse surgery. The type of treatment is determined by the patient’s overall health, comorbidities, performance status, preference, and other factors. It is important for clinicians to promptly diagnose and treat this deadly disease and to discuss which treatment option would be best for each patient.
Akhtar AN. Treatment Options for Stage I Non-Small Cell Lung Cancer. Lynchburg Journal of Medical Science. 2023; 5(2).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.